Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 30, 2022 | Post-IPO Equity | $80.40M | — | — | — | Detail |
Nov 3, 2021 | Post-IPO Equity | — | 1 | Ysios Capital | — | Detail |
Oct 29, 2021 | IPO | $75.60M | — | — | — | Detail |
Mar 22, 2021 | Series Unknown | $80M | 11 | Matrix Capital Management , Surveyor Capital | — | Detail |
Jul 9, 2020 | Series Unknown | $10M | — | — | — | Detail |
Jun 25, 2020 | Series D | — | 1 | — | — | Detail |
Apr 2, 2019 | Series D | $40M | 1 | Medicxi | — | Detail |
Dec 21, 2017 | Series C | $30M | 8 | Arix Bioscience , Lundbeckfonden Ventures | — | Detail |
Sep 29, 2016 | Series Unknown | $8M | — | — | — | Detail |
Mar 5, 2015 | Series B | $21M | 8 | Advent Life Sciences | — | Detail |
Aug 15, 2014 | Series Unknown | $4M | — | — | — | Detail |
Jan 8, 2014 | Debt Financing | $1.33M | — | — | — | Detail |
Dec 26, 2012 | Series Unknown | $3.22M | — | — | — | Detail |
Aug 26, 2011 | Series A | $3M | — | — | — | Detail |
Sep 1, 2010 | Series A | $1.40M | — | — | — | Detail |